A Glimpse Into The Expert Outlook On Pacific Biosciences Through 4 Analysts
A Glimpse Into The Expert Outlook On Pacific Biosciences Through 4 Analysts
通過四位分析師一窺太平洋生物科學專家展望
Across the recent three months, 4 analysts have shared their insights on Pacific Biosciences (NASDAQ:PACB), expressing a variety of opinions spanning from bullish to bearish.
在最近三個月中，4位分析師分享了他們對太平洋生物科學（納斯達克股票代碼：PACB）的見解，表達了從看漲到看跌的各種觀點。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表總結了他們最近的評級，展示了過去30天內不斷變化的情緒，並將其與前幾個月進行了比較。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $6.12, a high estimate of $12.00, and a low estimate of $2.50. This current average has decreased by 41.04% from the previous average price target of $10.38.
分析師評估的12個月目標股價揭示了進一步的見解，平均目標價爲6.12美元，最高估計爲12.00美元，低估值爲2.50美元。目前的平均價格較之前的平均目標價10.38美元下降了41.04％。
Understanding Analyst Ratings: A Comprehensive Breakdown
了解分析師評級：全面細分
The analysis of recent analyst actions sheds light on the...
對分析師近期行爲的分...
登入免費觀看全文
登入/註冊